Westside Investment Management, Inc. Crispr Therapeutics Ag Transaction History

Westside Investment Management, Inc.

  • $470 Billion
  • Q3 2024

A detailed history of Westside Investment Management, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Westside Investment Management, Inc. holds 6,442 shares of CRSP stock, worth $263,735. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,442
Previous 7,463 13.68%
Holding current value
$263,735
Previous $403 Million 23.63%
% of portfolio
0.07%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024
SELL
$44.62 - $62.75 $45,557 - $64,067
-1,021 Reduced 13.68%
6,442 $308 Million
Q2 2024

Jul 17, 2024
BUY
$51.17 - $68.18 $3,581 - $4,772
70 Added 0.95%
7,463 $403 Million
Q1 2024

Apr 19, 2024
BUY
$60.67 - $89.12 $20,142 - $29,587
332 Added 4.7%
7,393 $504 Million
Q4 2023

Jan 12, 2024
BUY
$38.62 - $72.18 $1,930 - $3,609
50 Added 0.71%
7,061 $442 Million
Q2 2023

Jul 14, 2023
SELL
$43.47 - $67.77 $5,172 - $8,064
-119 Reduced 1.67%
7,011 $394 Million
Q1 2023

May 17, 2023
SELL
$41.0 - $56.12 $24,600 - $33,672
-600 Reduced 7.76%
7,130 $322 Million
Q2 2022

Jul 15, 2022
SELL
$43.23 - $73.83 $8,646 - $14,766
-200 Reduced 2.52%
7,730 $469,000
Q1 2022

Apr 25, 2022
BUY
$53.19 - $79.24 $14,361 - $21,394
270 Added 3.52%
7,930 $497,000
Q4 2021

Feb 15, 2022
BUY
$70.09 - $111.29 $274,051 - $435,143
3,910 Added 104.27%
7,660 $580,000
Q3 2021

Oct 27, 2021
BUY
$110.2 - $156.64 $92,568 - $131,577
840 Added 28.87%
3,750 $419,000
Q2 2021

Jul 28, 2021
BUY
$100.84 - $161.89 $10,084 - $16,188
100 Added 3.56%
2,910 $471,000
Q1 2021

Apr 14, 2021
BUY
$110.72 - $210.04 $277,907 - $527,200
2,510 Added 836.67%
2,810 $342,000
Q4 2020

Jan 15, 2021
SELL
$79.67 - $173.23 $7,967 - $17,323
-100 Reduced 25.0%
300 $45,000
Q3 2020

Oct 14, 2020
SELL
$78.5 - $100.64 $16,642 - $21,335
-212 Reduced 34.64%
400 $33,000
Q2 2020

Jul 21, 2020
SELL
$38.5 - $76.05 $9,625 - $19,012
-250 Reduced 29.0%
612 $44,000
Q1 2020

Apr 16, 2020
BUY
$33.68 - $62.53 $25,664 - $47,647
762 Added 762.0%
862 $36,000
Q2 2018

Aug 13, 2018
BUY
$42.62 - $73.59 $4,262 - $7,359
100 New
100 $0
Q1 2018

Apr 16, 2018
SELL
$23.52 - $58.17 $2,352 - $5,817
-100 Closed
0 $0
Q2 2017

Aug 15, 2017
BUY
N/A
100
100 $0

Others Institutions Holding CRSP

# of Institutions
490
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.19B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email